For node-positive patients, Figure 2B demonstrates that TNBC breast carcinoma tends to show a worse 5-year DFS, by log-rank analysis, and that ER-positive and/or PgR-positive and HER2-negative patients have the best 5-year DFS (p = 0.0088). The gene discussed is PGR; the disease is breast carcinoma.